---
title: "China Resources Pharma's recombinant coagulation factor IX has received the clinical trial approval notice for drugs in mainland China"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276832369.md"
description: "China Resources Pharma announced that its subsidiary China Resources BOYA Biotechnology Group has received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration for human coagulation factor IX. This product is used for bleeding treatment in patients with coagulation factor IX deficiency (Hemophilia B)"
datetime: "2026-02-25T04:29:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276832369.md)
  - [en](https://longbridge.com/en/news/276832369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276832369.md)
---

# China Resources Pharma's recombinant coagulation factor IX has received the clinical trial approval notice for drugs in mainland China

China Resources Pharmaceutical (03320.HK) announced that its subsidiary China Resources BOYA Biotechnology Group received the Clinical Trial Approval Notice for Human Coagulation Factor IX issued by the National Medical Products Administration. This product is used for bleeding treatment in patients with Coagulation Factor IX deficiency (Hemophilia B)

### Related Stocks

- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [300294.CN](https://longbridge.com/en/quote/300294.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)

## Related News & Research

- [China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical](https://longbridge.com/en/news/294273054.md)